# David Soper, M.D. – FDA Inspection, Feb 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/david-soper-md/6f2adb40-b256-4a76-a809-a516e2f25c34
Source feed: FDA_Inspections

> FDA inspection 1042065 of David Soper, M.D., February 08, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042065
- Company Name: David Soper, M.D.
- Inspection Date: 2018-02-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ruth-a-williams/f6dd5e30-fe9a-4b18-9703-dc471a55f24f)

Company: https://www.keypedia.com/companies/david-soper-md/ee608f78-6453-48ed-9986-a06497f0e289

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c